ARKG holders · CITADEL ADVISORS LLC 13F · ARKG stock
CITADEL ADVISORS LLC ARK Genomic Revolution ETF (ARKG) 13F holding
CITADEL ADVISORS LLC reported 294,157 ARKG shares valued at $7.8M as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.
This is the newest ARKG 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the ARKG holders table.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-03-31 | 294,157 | $7.8M | GENOMIC REV ETF |
| 2025-12-31 | 36,148 | $1.0M | GENOMIC REV ETF |
| 2025-06-30 | 381,389 | $9.3M | GENOMIC REV ETF |
Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.